A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
Clinical trial NCT01892345 · TERMINATED
Trial details
- NCT number
- NCT01892345
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-11
- Primary completion
- 2018-07-17
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.